Skip to main content

Branded

  • FDA approves first drug for eye condition

    SILVER SPRING, Md. — The Food and Drug Administration has approved what it called the first drug to treat an eye condition that can interfere with the part of the retina responsible for reading vision.

    The agency announced the approval of Jetrea (ocriplasmin), made by Iselin, N.J.-based ThromboGenics. The drug is used to treat symptomatic vitreomacular adhesion.

  • Sanofi Pasteur seeks to expand seasonal flu protection from three influenza strains to four

     SWIFTWATER, Pa. — Sanofi Pasteur on Thursday announced it has filed for approval of a four-strain flu shot to the Food and Drug Administration. An action date is anticipated in the second quarter of 2013. 

  • CDC study finds drops in cholesterol levels since 1988

    NEW YORK — An uptick in the use of cholesterol drugs since the late 1980s and changes in Americans' diets may account for a fall in cholesterol levels, according to a new study by the Centers for Disease Control and Prevention.

  • FDA accepts regulatory filing for Depomed drug

    MENLO PARK, Calif. — The Food and Drug Administration has accepted a regulatory approval application for a drug for hot flashes from Depomed, the drug maker said.

    Depomed submitted its application to the FDA for Serada (gabapentin), an extended-release drug for hot flashes in menopausal women.

  • Bristol-Myers Squibb skin cancer drug wins Prix Galien USA Prize

    PRINCETON, N.J. — A cancer drug made by Bristol-Myers Squibb has received an award from Galien Foundation, the drug maker said Wednesday.

    The company said Yervoy (ipilimumab) received the 2012 Prix Galien USA Prize in the Best Biotechnology Product category. Yervoy — used to treat melanoma that has spread to other parts of the body, known as metastasis — is the first new drug for melanoma that is metastatic or can't be removed through surgery in more than a decade.

  • Medicine adherence, long-term care and provider status on agenda at NCPA meeting

    SAN DIEGO — The National Community Pharmacists Association released its third online pharmacy benefit manager video at the Association’s Annual Convention. Titled “Fed Up With Phil,” the video is part of campaign to create greater awareness of how pharmacy benefit managers can undermine the relationship between patients and their pharmacists.

  • Pfizer honored with NCPA 2012 Corporate Recognition Award

     SAN DIEGO — Pfizer on Monday was awarded the National Community Pharmacists Association 2012 Corporate Recognition Award at NCPA's 114th Annual Convention and Trade Exposition, the association announced Monday. 

  • NASA, Epiomed Therapeutics partner on development of scopolamine nasal spray

    HOUSTON — NASA's Johnson Space Center and Epiomed Therapeutics have signed an agreement to develop and commercialize a NASA-crafted, fast-acting nasal spray to fight motion sickness. 

X
This ad will auto-close in 10 seconds